Tag Archives: Thomas Lönngren

Former EMA Head Back in the Regulatory Saddle

His decade-long tenure as head of the European Medicines Agency (EMA) may have ended, but Thomas Lönngren is already back in the regulatory saddle as a strategic advisor to NDA Group, an independent consulting group focused on reducing wasted drug development costs, ensuring new medicines get to market faster, and “improving the performance of the […]
Posted in Europe, Global, leadership, Market Access, People, pricing, R&D, Regulatory | Also tagged , , , | Leave a comment

Exclusive Interview: The European Medicine Agency's Thomas Lönngren

The European Medicines Agency (EMA) is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. In return, EMA has made a virtue of necessity. It filled the regulatory […]
Posted in Europe, Global, leadership, People, Regulatory | Also tagged , , , | 2 Comments
  • Categories

  • Meta